Healthcare Industry News: K2M
News Release - November 4, 2011
K2M Debuts ALEUTIAN(R) Transforaminal-Lumbar (TLIF) II Interbody System and ALEUTIAN(R) Anatomically-Narrow (AN) Oblique Interbody System at 2011 North American Spine Society Annual MeetingLEESBURG, Va.--(Healthcare Sales & Marketing Network)-- K2M, Inc., a spinal device company developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today debuted two additions to the family of ALEUTIAN® Interbody Systems at the 2011 North American Spine Society (NASS) Annual Meeting in Chicago.
Furthering the company’s commitment to continue to enhance its extensive product portfolio, the ALEUTIAN Transforaminal-Lumbar (TLIF) II Interbody System features a full range of unique bulleted PEEK interbodies for posterior lumbar applications. The ALEUTIAN TILF II will include the Adjustable Inserter, which allows for variable angulation of the implant from 0° to 55° in-situ, helping the surgeon to insert the TLIF interbody with precision and ease. For oblique implant placement through a transforaminal-lumbar approach, the ALEUTIAN Anatomically-Narrow (AN) Oblique Interbody System offers innovative instrumentation that helps facilitate more efficient intraoperative use of the system.
“The bulleted nose of the ALEUTIAN TLIF II implant simplifies interbody insertion and the open-structure design provides a substantial amount of room for graft material. The implant features, combined with state-of-the-art instrument technology, makes the ALEUTIAN TLIF II Interbody System a great choice for my patients who require a transforaminal interbody fusion,” stated Dr. George Miz, Orthopedic Surgeon at Bone and Joint Physicians.
The clinical application of the ALEUTIAN Transforaminal-Lumbar II Interbody System will be shown in a Hands-On Demonstration at NASS, today from 10:00 – 10:30 am Central (K2M Booth #1616).
“K2M’s debut of two new next generation products in the ALEUTIAN family of products demonstrates our dedication to developing and improving upon our rapidly growing portfolio,” stated Eric Major, K2M’s President and CEO. “Given the significant expansion of our global distribution team and the number of new and existing customers in need of high quality interbody systems, it is critical that we continue to introduce new technologies.”
K2M, Inc. is an innovative spinal device company committed to the research, development, and commercialization of simplified solutions for the treatment of complex spinal pathologies and minimally invasive procedures. The company is recognized as a worldwide leader in providing unique technologies for the treatment of deformity, degenerative, trauma, and tumor spinal patients. K2M’s complete portfolio of next generation products includes: spinal stabilization systems, minimally invasive systems, and other advancing technologies such as motion preservation, annular repair, and nucleus replacement. Additional information is available online at www.K2M.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.